Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Wandt · SciRah

Researcher profile · Semantic Scholar

H. Wandt

Share profile

H. Wandt — researcher profile on SciRah

h-index: 46
Works: 181
Citations: 8,476

Most-cited papers

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
E. Hoster, M. Dreyling, W. Klapper, C. Gisselbrecht +16 more
2006Blood980 citations
Semantic Scholar
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the Germa
G. Lenz, M. Dreyling, E. Hoster, B. Wörmann +13 more
2005Journal of Clinical Oncology614 citations Open access
Semantic Scholar
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
N. Kroger, E. Holler, G. Kobbe, M. Bornhäuser +21 more
2009Blood381 citations Open access
Semantic Scholar
Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a pros
R. Forstpointner, M. Unterhalt, M. Dreyling, H. Böck +10 more
2006Blood356 citations Open access
Semantic Scholar
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial.
H. Serve, U. Krug, R. Wagner, M. Sauerland +23 more
2013Journal of Clinical Oncology311 citations Open access
Semantic Scholar
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
H. Wandt, K. Schaefer-Eckart, K. Wendelin, Bettina Pilz +16 more
2012The Lancet310 citations
Semantic Scholar
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
J. Pico, G. Rosti, A. Kramar, H. Wandt +13 more
2005Annals of Oncology265 citations Open access
Semantic Scholar
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.
C. Röllig, M. Bornhäuser, C. Thiede, F. Taube +13 more
2011Journal of Clinical Oncology256 citations
Semantic Scholar
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial.
C. Röllig, C. Thiede, M. Gramatzki, W. Aulitzky +15 more
2010Blood175 citations
Semantic Scholar
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
S. de Botton, M. A. Sanz, S. Chevret, H. Dombret +18 more
2006Leukemia161 citations Open access
Semantic Scholar
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C. Buske, E. Hoster, M. Dreyling, H. Eimermacher +16 more
2009Leukemia153 citations
Semantic Scholar
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT
H. Hebart, L. Klingspor, T. Klingebiel, J. Loeffler +11 more
2009Bone Marrow Transplantation120 citations Open access
Semantic Scholar
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.
M. Schaich, C. Röllig, Silke Soucek, M. Kramer +16 more
2011Journal of Clinical Oncology104 citations
Semantic Scholar
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
A. Glasmacher, O. Cornely, A. Ullmann, U. Wedding +10 more
2006Journal of Antimicrobial Chemotherapy103 citations Open access
Semantic Scholar
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas
C. Nickenig, M. Dreyling, E. Hoster, M. Pfreundschuh +6 more
2006Cancer101 citations
Semantic Scholar
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.
V. Möbus, H. Wandt, N. Frickhofen, C. Bengala +5 more
2007Journal of Clinical Oncology90 citations
Semantic Scholar
A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation
H. Wandt, K. Schaefer-Eckart, Markus Frank, Josef Birkmann +1 more
2006Bone Marrow Transplantation90 citations Open access
Semantic Scholar
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
V. Jurinovic, B. Metzner, M. Pfreundschuh, N. Schmitz +8 more
2018Biology of Blood and Marrow Transplantation81 citations Open access
Semantic Scholar
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
J. Casper, D. Wolff, W. Knauf, I. Blau +14 more
2010Journal of Clinical Oncology79 citations Open access
Semantic Scholar
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience.
U. de Giorgi, T. Demirer, H. Wandt, C. Taverna +6 more
2005Annals of Oncology79 citations Open access
Semantic Scholar
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients.
H. Wandt, U. Schäkel, F. Kroschinsky, G. Prange-krex +6 more
2008Blood76 citations
Semantic Scholar
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial.
C. Röllig, M. Bornhäuser, M. Kramer, C. Thiede +22 more
2015Journal of Clinical Oncology75 citations Open access
Semantic Scholar
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
J. Casper, Jerzy Hołowiecki, R. Trenschel, H. Wandt +18 more
2012Bone Marrow Transplantation56 citations Open access
Semantic Scholar
Platelet transfusion in hematology, oncology and surgery.
H. Wandt, K. Schäfer-Eckart, A. Greinacher
2014Deutsches Ärzteblatt International51 citations Open access
Semantic Scholar
Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).
H. Einsele, P. Liebisch, C. Langer, M. Kropff +38 more
200951 citations
Semantic Scholar
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study
M. Bornhäuser, N. Kroger, R. Schwerdtfeger, K. Schäfer-Eckart +11 more
2006European Journal of Haematology48 citations
Semantic Scholar
Sorafenib In Combination with Standard Induction and Consolidation Therapy In Elderly AML Patients: Results From a Randomized, Placebo-Controlled Phase II Trial
H. Serve, R. Wagner, C. Sauerland, U. Brunnberg +23 more
201047 citations
Semantic Scholar
Combined immuno-chemotherapy (R-FCM) results in superior remission rates and overall survival in recurrent follicular and mantle cell lymphoma: Follow-up of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
M. Dreyling, R. Forstpointner, W. Ludwig, M. Gramatzki +6 more
200538 citations
Semantic Scholar
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial
C. Straka, P. Liebisch, H. Salwender, B. Hennemann +31 more
2016Haematologica34 citations Open access
Semantic Scholar
The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial
E. Hoster, M. Unterhalt, B. Wörmann, U. Duhrsen +10 more
200833 citations
Semantic Scholar
Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*
U. Schuler, S. Bammer, W. Aulitzky, C. Binder +8 more
2007Oncology Research and Treatment32 citations Open access
Semantic Scholar
Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.
S. Knop, P. Liebisch, H. Hebart, E. Holler +26 more
200930 citations
Semantic Scholar
WHO classification of myeloid neoplasms and leukemia.
H. Wandt, T. Haferlach, C. Thiede, G. Ehninger
2010Blood27 citations
Semantic Scholar
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
H. Einsele, S. Knop, M. Vogel, J. Müller +17 more
2017Leukemia24 citations
Semantic Scholar
Combined Immuno-Chemotherapy (R-CHOP) Results in Significantly Superior Response Rates and Time to Treatment Failure in First Line Treatment of Patients with Lymphomplasmocytoid/ic Immunocytoma (LP-IC) - Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG).
C. Buske, M. Dreyling, H. Eimermacher, H. Boeck +15 more
200423 citations
Semantic Scholar
Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
S. Knop, Peter Liebisch, H. Hebart, E. Holler +26 more
201422 citations
Semantic Scholar
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.
A. Zander, C. Schmoor, N. Kroger, W. Krüger +11 more
2008Annals of Oncology22 citations Open access
Semantic Scholar
AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia
Friederike Schneider, S. K. Bohlander, S. Schneider, C. Papadaki +10 more
2007Leukemia21 citations Open access
Semantic Scholar
Bortezomib, IV cyclophosphamide, and dexamethasone (VelCD) as induction therapy in newly diagnosed multiple myeloma: Results of an interim analysis of the German DSMM Xia trial.
S. Knop, P. Liebisch, H. Wandt, M. Kropff +6 more
2009Journal of Clinical Oncology18 citations
Semantic Scholar
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.
C. Straka, M. Sandherr, H. Salwender, H. Wandt +19 more
2011Blood17 citations
Semantic Scholar
Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
N. Kroeger, E. Holler, G. Kobbe, M. Bornhaeuser +23 more
200717 citations
Semantic Scholar
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
Carmelo Bengala, V. Guarneri, J. Ledermann, G. Rosti +7 more
2005Bone Marrow Transplantation17 citations Open access
Semantic Scholar
Results from two phase III studies of bortezomib (BTZ) consolidation vs observation (OBS) post-transplant in patients (pts) with newly diagnosed multiple myeloma (NDMM).
C. Straka, M. Vogel, Jürgen Müller, M. Kropff +15 more
201515 citations
Semantic Scholar
Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients.
H. Wandt, K. Schaefer-Eckart, Bettina Pilz, M. Thalheimer +11 more
200915 citations
Semantic Scholar
A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantat
H. Wandt, K. Wendelin, K. Schaefer-Eckart, M. Thalheimer +9 more
200815 citations
Semantic Scholar
Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support.
H. Wandt, K. Schaefer-Eckart, M. Wilhelm
2005Haematologica15 citations
Semantic Scholar
Prophylactic platelet transfusion.
H. Wandt, K. Schäfer-Eckart, G. Ehninger
2013New England Journal of Medicine14 citations
Semantic Scholar
Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients
C. Straka, K. Schäfer-Eckart, F. Bassermann, B. Hertenstein +26 more
201213 citations
Semantic Scholar
Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.
N. Kroger, H. Einsele, G. Derigs, H. Wandt +2 more
2010Biology of Blood and Marrow Transplantation11 citations Open access
Semantic Scholar
A phase III randomised trial of sequential high dose chemotherapy (HDC) with peripheral blood stem cell support or standard dose Chemotherapy (SDC) for first-line treatment of ovarian cancer
J. Ledermann, N. Frickhofen, H. Wandt, C. Bengala +3 more
200511 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Metzner×16
Invite
B. Metzner — researcher profile on SciRah
H. Einsele×16
Invite
H. Einsele — researcher profile on SciRah
G. Ehninger×14
Invite
G. Ehninger — researcher profile on SciRah
M. Unterhalt×10
Invite
M. Unterhalt — researcher profile on SciRah

×10

Invite

M. Schaich — researcher profile on SciRah

W. Aulitzky×10

Invite

W. Aulitzky — researcher profile on SciRah

Invite

M. Dreyling — researcher profile on SciRah

Invite

C. Thiede — researcher profile on SciRah

M. Gramatzki×8

Invite

M. Gramatzki — researcher profile on SciRah

Invite

C. Straka — researcher profile on SciRah

Invite

W. Jung — researcher profile on SciRah

W. Hiddemann×7

Invite

W. Hiddemann — researcher profile on SciRah